2024
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non–Small Cell Lung Cancer
Rodrigues G, Higgins K, Rimner A, Amini A, Chang J, Chun S, Donington J, Edelman M, Gubens M, Iyengar P, Movsas B, Ning M, Park H, Wolf A, Simone C. American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non–Small Cell Lung Cancer. JAMA Oncology 2024, 10: 799-806. PMID: 38602670, PMCID: PMC11665040, DOI: 10.1001/jamaoncol.2024.0294.Peer-Reviewed Original ResearchConceptsLocally advanced non-small cell lung cancerAmerican Radium Society Appropriate Use CriteriaAdvanced non-small cell lung cancerAmerican Radium SocietyAppropriate use criteriaNon-small cell lung cancerLA-NSCLCUnresectable LA-NSCLCCell lung cancerTreatment of locally advanced non-small cell lung cancerUnresectable locally advanced non-small cell lung cancerLung cancerIntensity-modulated radiotherapy techniqueDecades of clinical trialsPlatinum-based chemoradiationLung cancer radiotherapyEvidence-based consensus documentMultidisciplinary patient careEvidence-based guidelinesRadiotherapy techniquesSalvage therapyFractionation schedulesLocal recurrenceSystemic therapyCancer radiotherapy
2019
Adaptive Imaging Versus Periodic Surveillance for Intrafraction Motion Management During Prostate Cancer Radiotherapy
Ma X, Yan H, Nath R, Chen Z, Li H, Liu W. Adaptive Imaging Versus Periodic Surveillance for Intrafraction Motion Management During Prostate Cancer Radiotherapy. Technology In Cancer Research & Treatment 2019, 18: 1533033819844489. PMID: 31177934, PMCID: PMC6558533, DOI: 10.1177/1533033819844489.Peer-Reviewed Original ResearchConceptsIntensity-modulated radiation therapyRadiation therapyCouch shiftsAutomatic motion compensationAdaptive imagingAutomatic correctionCurrent clinical situationProstate cancer radiotherapyImaging surveillanceMotion compensationPeriodic imaging surveillanceProstate cancerPeriodic surveillanceClinical situationsSurveillance strategiesBenefits of adaptivePeriodic imagingArc therapyMean percentageTherapyIntrafraction motion managementCancer radiotherapyRadiation therapy simulationTherapy simulationBeam delivery
2016
Radiation-induced heart disease in lung cancer radiotherapy
Ming X, Feng Y, Yang C, Wang W, Wang P, Deng J. Radiation-induced heart disease in lung cancer radiotherapy. Medicine 2016, 95: e5051. PMID: 27741117, PMCID: PMC5072944, DOI: 10.1097/md.0000000000005051.Peer-Reviewed Original ResearchConceptsRadiation-induced heart diseaseLung cancer radiotherapyLung cancer patientsPotential risk factorsCancer radiotherapyCancer patientsCardiac toxicityHeart diseaseRisk factorsRadiation treatmentLung cancer survivorsLate side effectsHistory of heartTypes of cancerCardiac complicationsCrude incidencePulmonary diseaseBetter prognosisLobar locationBenign diseaseCancer survivorsLung cancerTreatment modalitiesPatient prognosisBreast cancer
2014
Radiation-Induced Changes in Serum Lipidome of Head and Neck Cancer Patients
Jelonek K, Pietrowska M, Ros M, Zagdanski A, Suchwalko A, Polanska J, Marczyk M, Rutkowski T, Skladowski K, Clench MR, Widlak P. Radiation-Induced Changes in Serum Lipidome of Head and Neck Cancer Patients. International Journal Of Molecular Sciences 2014, 15: 6609-6624. PMID: 24747595, PMCID: PMC4013650, DOI: 10.3390/ijms15046609.Peer-Reviewed Original ResearchConceptsSerum lipidomeConformal radiotherapyMedium dosesEnd of radiotherapyNeck cancer patientsRadiation-induced changesWhole patient bodyBody responsePost-treatment samplesDoses of radiationBlood levelsCancer patientsNeck cancerBlood samplesRadiotherapyNormal tissuesPatientsDosesCancer radiotherapyLipidomePatient's bodyTreatment samplesTissueLipid extractsCancer
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply